Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 1500 of 1674 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/01/10
End: 06/01/16
Due: 06/01/17
Phase: N/A
Priority: Normal
Start: 08/14/24
End: 12/31/28
Due: 12/31/29
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Phase: N/A
Priority: Normal
Start: 10/02/24
End: 02/28/31
Due: 02/28/32
Phase: N/A
Priority: Normal
Start: 06/08/18
End: 10/28/24
Due: 10/28/25
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 01/13/14
End: 05/10/18
Due: 05/10/19
Phase: N/A
Priority: Normal
Start: 02/14/20
End: 11/21/24
Due: 11/21/25
Phase: N/A
Priority: Normal
Start: 10/14/22
End: 03/22/24
Due: 03/22/25
Phase: N/A
Priority: Normal
Start: 09/22/22
End: 01/20/23
Due: 01/20/24
Phase: N/A
Priority: Normal
Start: 11/29/21
End: 09/01/26
Due: 09/01/27
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 06/28/22
End: 05/27/26
Due: 05/27/27
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 09/01/17
End: 12/31/24
Due: 12/31/25
Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions
Phase: N/A
Priority: Normal
Start: 07/13/18
End: 11/23/21
Due: 11/23/22
Phase: N/A
Priority: Normal
Start: 09/10/20
End: 01/01/30
Due: 01/01/31
Phase: N/A
Priority: Normal
Start: 09/20/22
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 10/10/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 01/05/22
End: 05/01/22
Due: 05/01/23
Phase: N/A
Priority: Normal
Start: 07/15/22
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: -
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 03/14/28
Due: 03/14/29